- Home
- AVTX vs AMTX Comparison
AVTX vs AMTX Comparison
Compare AVTX & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- AMTX
- Stock Information
- Founded
- AVTX 2011
- AMTX 2005
- Country
- AVTX United States
- AMTX United States
- Employees
- AVTX N/A
- AMTX N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- AMTX Major Chemicals
- Sector
- AVTX Health Care
- AMTX Industrials
- Exchange
- AVTX Nasdaq
- AMTX Nasdaq
- Market Cap
- AVTX 138.8M
- AMTX 150.1M
- IPO Year
- AVTX 2015
- AMTX N/A
- Fundamental
- Price
- AVTX $13.50
- AMTX $2.99
- Analyst Decision
- AVTX Strong Buy
- AMTX Strong Buy
- Analyst Count
- AVTX 9
- AMTX 3
- Target Price
- AVTX $30.14
- AMTX $17.33
- AVG Volume (30 Days)
- AVTX 451.4K
- AMTX 1.2M
- Earning Date
- AVTX 11-06-2025
- AMTX 11-11-2025
- Dividend Yield
- AVTX N/A
- AMTX N/A
- EPS Growth
- AVTX N/A
- AMTX N/A
- EPS
- AVTX N/A
- AMTX N/A
- Revenue
- AVTX $441,000.00
- AMTX $223,574,000.00
- Revenue This Year
- AVTX N/A
- AMTX $14.06
- Revenue Next Year
- AVTX N/A
- AMTX $108.78
- P/E Ratio
- AVTX N/A
- AMTX N/A
- Revenue Growth
- AVTX N/A
- AMTX N/A
- 52 Week Low
- AVTX $3.39
- AMTX $1.22
- 52 Week High
- AVTX $16.00
- AMTX $4.73
- Technical
- Relative Strength Index (RSI)
- AVTX 65.78
- AMTX 68.70
- Support Level
- AVTX $12.41
- AMTX $2.19
- Resistance Level
- AVTX $14.73
- AMTX $2.56
- Average True Range (ATR)
- AVTX 0.94
- AMTX 0.23
- MACD
- AVTX 0.13
- AMTX 0.08
- Stochastic Oscillator
- AVTX 70.97
- AMTX 78.41
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.